Himmelreich Jeffrey C bought MAIA
May 29, 2026 · Form 4 insider transaction
Himmelreich Jeffrey C bought 60,000 shares of MAIA Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderHimmelreich Jeffrey C
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.